BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

HWKN: Rising Gross Margin Profile, PT to $122

HWKN: Sales Mix Change Is a PT Change, Now $96

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul>
<li>HWKN reported fiscal second quarter (September) results where lower selling prices for industrial chemicals led to sales missing our estimates. </li>
<li>The lack of sales compared to our forecast resulted in HWKN slightly missing our EPS estimate. The offsetting factor was higher gross margin as a result of lower feedstock costs. </li>
<li>We are making changes to our earnings model for fiscal 2025 and 2026. The biggest factor is the assumption the lower ASPs in the industrial segment would continue.</li>
</ul>


HWKN reported fiscal second quarter (September) results where lower selling prices for industrial chemicals led to sales missing our estimates. 
The lack of sales compared to our forecast resulted in HWKN slightly missing our EPS estimate. The offsetting factor was higher gross margin as a result of lower feedstock costs. 
We are making changes to our earnings model for fiscal 2025 and 2026. The biggest factor is the assumption the lower ASPs in the industrial segment would continue.


Hawkins Inc

HWKN: No Treat of a Season